Compare Enzyme (MLN) vs Neuron (NRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs Neuron — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Neuron trades at Rp63.99 (market cap Rp26,48M, Rp841,43jt 24h volume). The key difference: Enzyme is far larger — about 5.1× Neuron's market cap, and Neuron's supply is capped (358,6M / 1B NRN (36%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Neuron for 10 Days on average.
| MLN | NRN | |
|---|---|---|
Market Cap | Rp134,13M | Rp26,48M |
Volume (24h) | Rp104,56M | Rp841,43jt |
Circulating Supply | 3,3M MLN | 358,6M / 1B NRN (36%) |
Typical Hold Time | 28 Days | 10 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Neuron (NRN) is a low-market-cap cryptocurrency with a market cap of Rp26.48M and a circulating supply of 358,600 tokens out of a maximum 1 million. Current price data is unavailable, but the asset shows a short hold time of 10 days, suggesting active trading. No recent protocol updates or ecosystem developments are noted. Trading activity appears limited, with no significant technical or fundamental catalysts driving momentum in the near term.
The outlook for NRN is cautious due to its small market cap and low liquidity, which heighten volatility risks. Opportunities exist if the project gains adoption or listings, but major risks include extreme price swings and low investor interest. Investors should monitor for any network growth or exchange additions to reassess potential.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About Neuron
NRN is developing an ecosystem aimed at accelerating the journey toward Artificial General Intelligence (AGI), using Gaming and robotics as experimental platforms. At its core is NRN Agents, a platform that facilitates the integration of AI agents within advanced Gaming experiences in both virtual and physical environments. The technology stack combines data aggregation, model training, and model inspection, utilizing both imitation learning and reinforcement learning to advance AI development.
Read more on NRN →
